Showing results (201-210 of 356) with videos related to

Sort By:
Pageof 36
Nutrients|September 28, 2021
Physical Growth of Patients with Hereditary Tyrosinaemia Type I: A Single-Centre Retrospective StudyOzlem Yilmaz, Anne Daly, Alex Pinto, et al.
European Journal of Gastroenterology & Hepatology|June 18, 2010
Detection of pancreatic adenocarcinoma using circulating fragments of fibrinogenDouglas G Ward, Wenbin Wei, John Buckels, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|December 2, 2015
Hyaluronic acid/carboxymethyl cellulose directly applied to transected nerve decreases axonal outgrowthAouod Agenor, Lucas Dvoracek, Ann Leu, et al.
Journal of Hepatology|February 15, 2003
Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expressionNathalie Wong, Andrew Chan, Siu-Wah Lee, et al.
Experimental Neurology|February 4, 2010
Matching of motor-sensory modality in the rodent femoral nerve model shows no enhanced effect on peripheral nerve regenerationDavid H Kawamura, Philip J Johnson, Amy M Moore, et al.
Proteome Science|June 19, 2008
Proteomic profiling of urine for the detection of colon cancerDouglas G Ward, Stephen Nyangoma, Howard Joy, et al.
International Journal of Cancer|January 13, 2005
Transcriptional profiling on chromosome 19p indicated frequent downregulation of ACP5 expression in hepatocellular carcinomaKathy Y-Y Chan, Nathalie Wong, Paul B-S Lai, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 13, 2025
Placental Growth Factor Led Management of the Small for Gestational Age Fetus: Randomised Controlled Feasibility StudySiân Bullough, Michelle Dower, Richard Jackson, et al.
Emergency Medicine Journal : EMJ|April 11, 2025
Salbutamol for analgesia in renal colic: a prospective, randomised, placebo-controlled phase II trialGraham D Johnson, Andrew Tabner, Apostolos Fakis, et al.
Clinical Schizophrenia & Related Psychoses|November 5, 2014
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophreniaLeslie Citrome, Peter J Weiden, Gus Alva, et al.
Pageof 36